Wolverine Trading
LABU icon

Wolverine Trading’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Wolverine Trading’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-61,900
Closed -$4.28M – 5203
2025
Q1 		$4.28M Sell
61,900
-45,500
-42% -$3.88M 0.01% 1074
2024
Q4 		$9.62M Buy
107,400
+1,000
+0.9% +$118K 0.01% 805
2024
Q3 		$13.5M Sell
106,400
-1,600
-1% -$209K 0.01% 563
2024
Q2 		$12.3M Sell
108,000
-18,200
-14% -$1.95M 0.01% 560
2024
Q1 		$16.7M Sell
126,200
-287,500
-69% -$37.5M 0.02% 452
2023
Q4 		$50.5M Buy
413,700
+387,315
+1,468% +$29.6M 0.05% 208
2023
Q3 		$2.01M Buy
26,385
+3,180
+14% +$326K ﹤0.01% 1585
2023
Q2 		$2.69M Sell
23,205
-345
-1% -$43K ﹤0.01% 1302
2023
Q1 		$2.19M Sell
23,550
-17,395
-42% -$2.36M ﹤0.01% 1315
2022
Q4 		$5.79M Sell
40,945
-2,205
-5% -$308K 0.01% 825
2022
Q3 		$5.95M Buy
43,150
+1,910
+5% +$350K 0.01% 763
2022
Q2 		$5.68M Buy
41,240
+11,545
+39% +$1.97M 0.01% 763
2022
Q1 		$9.51M Buy
29,695
+3,325
+13% +$1.25M 0.01% 719
2021
Q4 		$19.7M Buy
26,370
+15,840
+150% +$15.2M 0.02% 473
2021
Q3 		$11.6M Buy
10,530
+4,270
+68% +$5.25M 0.01% 736
2021
Q2 		$9.28M Buy
6,260
+2,795
+81% +$3.88M 0.01% 732
2021
Q1 		$4.85M Buy
+3,465
New +$8.12M 0.01% 1138
2020
Q4 		– Sell
-5,485
Closed -$5.93M – 5166
2020
Q3 		$5.93M Buy
+5,485
New +$6.29M 0.01% 762
2020
Q2 		– Sell
-5,695
Closed -$2.63M – 4923
2020
Q1 		$2.63M Buy
+5,695
New +$5.18M 0.01% 1136
2019
Q1 		– Sell
-9,610
Closed -$5.86M – 4925
2018
Q4 		$5.86M Buy
9,610
+4,055
+73% +$4.25M 0.02% 721
2018
Q3 		$10.3M Buy
+5,555
New +$10.9M 0.02% 537

Other funds holding LABU

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's LABU Position: Q2 2025 in Review

Wolverine Trading sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2025, closing a stake of 6,242 shares — an estimated $431K sold.

Wolverine Trading first reported a position in LABU in Q3 2018 and held it in 18 quarters. The position peaked at $3.56M in Q4 2021. 33 funds tracked by Wall St. Rank hold LABU as of Q2 2025.

  • Wolverine Trading reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 6,242 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2025, an estimated $431K.
  • Wolverine Trading first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2018 and held it in 18 quarters.
  • Wolverine Trading's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.56M in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.